NEW YORK (GenomeWeb) – Genomic Health reported after the close of the market Tuesday that its third quarter revenues rose 12 percent year over year, driven by an 8 percent increase in tests delivered during the quarter.

For the three months ended Sept. 30, the molecular diagnostics firm reported total revenues of $82.3 million, compared to $73.6 million in the year-ago quarter. This fell slightly short of the consensus Wall Street estimate of $83.2 million for Q3 2016.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.